Overview

Oxaliplatin for Children With Solid Tumors

Status:
Unknown status

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the pediatric neoplastic response to chemotherapy proposed and evaluate sensitivity to oxaliplatin through immunohistochemistry ERCC-1 expression analysis.

Phase:

Phase 2

Details

Lead Sponsor:

Sidnei Epelman

Treatments:

Oxaliplatin